2,4-Diphenyl-6-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrimidine, 98%, 5g

3-Fluoro-5-methoxyphenylboronic acid, 98.0%, 1g

3,5,6-Tribromopyrazin-2-amine, 95.0%, 100mg

2,2-Dimethyl-4-oxo-3,8,11,14-tetraoxa-5-azahexadecan-16-yl 4-methylbenzenesulfonate, 95%, 25g

Éter monobutílico de propilenglicol, mín. 99 %, para síntesis, 5 l, envase de plástico.

3-Nitroimidazo[1,2-b]pyridazine, 95%, 500mg

3-(2-aminoethyl)-5-(4-chlorobenzyl)oxazolidine-2,4-dione hydrochloride, 1g

5-Fluoro-4-methoxypicolinonitrile, 95%, 1g

1-Thio-beta-D-glucose tetraacetate, 99%, 5g

Bis(2,4-pentanedionato)zinc(II)>96.0%(T)100g

2-Isopropoxy-4-methoxybenzonitrile, 97%, 5g

3-(1-Oxo-1,3-dihydro-isoindol-2-yl)-propionic acid, 95.0%, 1g

2-(2-Ethoxyethoxy)ethyl acetate, 98%, 500g